- Home
- / Tiansheng Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Tiansheng Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥4.4
2024-10-29
Market Capitalization
¥1.4 B
2024-10-29
Revenue
¥515.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.1B | 1.6B | 1.2B | 701.6M | 565.5M | 526.0M | 515.7M |
| Cost of goods sold | 1.5B | 1.2B | 852.8M | 432.7M | 263.6M | 306.6M | 298.2M |
| Gross profit | 605.5M | 454.5M | 336.6M | 292.7M | 331.7M | 258.3M | 258.3M |
| Gross profit margin, % | 28.5% | 27.6% | 28.9% | 41.7% | 58.7% | 49.1% | 50.1% |
| Operating expense total | 428.2M | 594.9M | 358.1M | 273.3M | 329.1M | 244.9M | 213.0M |
| Depreciation and amortization | 113.1M | 9.3M | 470.8M | 91.8M | 105.5M | 108.9M | 130.3M |
| EBITDA | 177.3M | (140.4M) | (21.5M) | 19.4M | 5.4M | 14.7M | 40.0M |
| EBITDA margin, % | 8.3% | -8.5% | -1.8% | 2.8% | 1.0% | 2.8% | 7.8% |
| EBIT | 76.1M | (201.4M) | (500.3M) | (50.4M) | (81.0M) | (89.7M) | (107.1M) |
| EBIT margin, % | 3.6% | -12.2% | -42.9% | -7.2% | -14.3% | -17.1% | -20.8% |
| Interest income | 2.0M | 1.5M | 5.9M | 16.8M | 7.5M | 8.4M | 8.7M |
| Interest expense | 42.2M | 37.7M | 38.9M | 24.4M | 15.8M | 15.0M | 14.8M |
| Pre tax profit | 37.0M | (230.8M) | (534.6M) | (54.4M) | (84.1M) | (94.7M) | (97.8M) |
| Income tax expense | 21.4M | (10.7M) | (41.0M) | 17.9M | 7.4M | (1.0M) | (9.6M) |
| Net Income | 15.6M | (220.1M) | (493.6M) | (72.3M) | (91.6M) | (93.7M) | (88.1M) |